Chairman
Amir Hasidim serves as Chairman of Apex Bio, providing visionary leadership and strategic oversight to guide the company’s growth in the biotech sector. With extensive executive experience across technology and life sciences, Mr. Hasidim is instrumental in shaping Apex Bio’s mission to develop innovative solutions for neurodegenerative diseases and brain health.
As Chairman, Amir leverages his deep understanding of business development, corporate governance, and enterprise strategy to foster partnerships, secure investment, and drive organizational excellence. He supports the executive team in implementing long-term goals, opening global opportunities, and ensuring Apex Bio remains at the forefront of scientific advancement and patient-focused innovation.
Prior to his role at Apex Bio, Amir held senior leadership positions in startups and established companies, where he demonstrated expertise in operational management, corporate finance, and the commercialization of cutting-edge technologies. He is recognized for his commitment to integrity, collaboration, and sustainable growth within high-impact, values-driven organizations.
Under his chairmanship, Apex Bio continues to expand its industry presence and accelerate its vision of transforming brain health through scientific discovery and medical innovation.